83 related articles for article (PubMed ID: 5120302)
1. Differential effects of melphalan on mouse myeloma (adj. PC-5) and hemopoietic stem cells.
Ogawa M; Bergsagel DE; McCulloch EA
Cancer Res; 1971 Dec; 31(12):2116-9. PubMed ID: 5120302
[No Abstract] [Full Text] [Related]
2. Effects of Dintrato(1,2-diaminocyclohexane)platinum (NSC 239851) On murine myeloma and hemopoietic precursor cells.
Ogawa M; Gale GR; Meischen SJ; Cooke VA
Cancer Res; 1976 Sep; 36(9 pt.1):3185-8. PubMed ID: 975083
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.
Salmon SE; Hamburger AW; Soehnlen B; Durie BG; Alberts DS; Moon TE
N Engl J Med; 1978 Jun; 298(24):1321-7. PubMed ID: 77475
[TBL] [Abstract][Full Text] [Related]
4. Oral melphalan at diagnosis hampers adequate collection of peripheral blood progenitor cells in multiple myeloma.
Boccadoro M; Palumbo A; Bringhen S; Merletti F; Ciccone G; Richiardi L; Rus C; Bertola A; Giaccone L; Omedè P; Musto P
Haematologica; 2002 Aug; 87(8):846-50. PubMed ID: 12161361
[TBL] [Abstract][Full Text] [Related]
5. Survival of hematopoietic and lymphoma colony-forming cells in vivo following the administration of a variety of alkylating agents.
Valeriote FA; Tolen SJ
Cancer Res; 1972 Mar; 32(3):470-6. PubMed ID: 4621955
[No Abstract] [Full Text] [Related]
6. In vitro maintenance and retroviral transduction of human myeloma cells in long-term marrow cultures.
Stewart AK; Prince HM; Cappe D; Chu P; Lutzko C; Sutherland DR; Dubé ID
Cancer Gene Ther; 1997; 4(3):148-56. PubMed ID: 9171933
[TBL] [Abstract][Full Text] [Related]
7. The Bcl-2 family protein inhibitor, ABT-737, has substantial antimyeloma activity and shows synergistic effect with dexamethasone and melphalan.
Trudel S; Stewart AK; Li Z; Shu Y; Liang SB; Trieu Y; Reece D; Paterson J; Wang D; Wen XY
Clin Cancer Res; 2007 Jan; 13(2 Pt 1):621-9. PubMed ID: 17255285
[TBL] [Abstract][Full Text] [Related]
8. In vitro cloning and chemosensitivity of human myeloma stem cells.
Salmon SE
Clin Haematol; 1982 Feb; 11(1):47-63. PubMed ID: 6176384
[No Abstract] [Full Text] [Related]
9. Effect, with time, of melphalan on hematopoietic stem cells proliferating at different rates.
Dunn CD
J Natl Cancer Inst; 1974 Jan; 52(1):173-80. PubMed ID: 4810960
[No Abstract] [Full Text] [Related]
10. Interleukin-6 affects melphalan-induced DNA damage and repair in human multiple myeloma cells.
Efferth T; Fabry U; Osieka R
Anticancer Res; 2002; 22(1A):231-4. PubMed ID: 12017294
[TBL] [Abstract][Full Text] [Related]
11. [Effect of the stem cell inhibitory factor on the formation of hemopoietic colonies].
Golovanova TA; Kaulen DR; Kuralesova AI; Ignat'eva OIu
Ontogenez; 1982; 13(3):243-50. PubMed ID: 7048175
[TBL] [Abstract][Full Text] [Related]
12. Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model.
Hazlehurst LA; Enkemann SA; Beam CA; Argilagos RF; Painter J; Shain KH; Saporta S; Boulware D; Moscinski L; Alsina M; Dalton WS
Cancer Res; 2003 Nov; 63(22):7900-6. PubMed ID: 14633719
[TBL] [Abstract][Full Text] [Related]
13. [Does the hematopoietic stem cell exist?].
Chertkov IL
Mol Biol (Mosk); 1984; 18(3):565-73. PubMed ID: 6381989
[TBL] [Abstract][Full Text] [Related]
14. Dose-intensive melphalan with stem cell support (CM regimen) is effective and well tolerated in elderly myeloma patients.
Palumbo A; Triolo S; Baldini L; Callea V; Capaldi A; De Stefano V; Grasso M; Liberati M; Lotesoriere C; Marcenò R; Marmont F; Musto P; Petrucci MT; Spriano M; Pileri A; Boccadoro M
Haematologica; 2000 May; 85(5):508-13. PubMed ID: 10800168
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with interleukin-6 receptor superantagonist Sant7 and dexamethasone induces antitumor effects in a novel SCID-hu In vivo model of human multiple myeloma.
Tassone P; Neri P; Burger R; Savino R; Shammas M; Catley L; Podar K; Chauhan D; Masciari S; Gozzini A; Tagliaferri P; Venuta S; Munshi NC; Anderson KC
Clin Cancer Res; 2005 Jun; 11(11):4251-8. PubMed ID: 15930364
[TBL] [Abstract][Full Text] [Related]
16. In vitro effect of isoprenaline on radiosensitivity of hemopoietic stem cells.
Kwiek S; Lipski S
Acta Pol Pharm; 1982; 39(5-6):469-73. PubMed ID: 7171017
[No Abstract] [Full Text] [Related]
17. Mobilization of peripheral blood stem cells with chemotherapy and cytokines in multiple myeloma.
Hénon PR; Becker M; Sovalat H; Eisenmann JC; Donatini B; Sklenar I
Stem Cells; 1995 Aug; 13 Suppl 2():148-55. PubMed ID: 8520504
[TBL] [Abstract][Full Text] [Related]
18. Differentiation and proliferative kinetics of hemopoietic stem cells in culture.
Ogawa M; Suda T; Suda J
Prog Clin Biol Res; 1984; 148():35-43. PubMed ID: 6379672
[No Abstract] [Full Text] [Related]
19. [Effect of prodigiozan on the state of the hemopoietic and stromal precursor cells in mouse bone marrow and spleen].
Levina NA; Lebedev VG
Patol Fiziol Eksp Ter; 1993; (2):37-9. PubMed ID: 8058382
[No Abstract] [Full Text] [Related]
20. Impaired PBPC collection in patients with myeloma after high-dose melphalan.
Jansen J; Thompson J; Dugan M; Wiemann M; Hanks S; Greenspan A; Akard L
Cytotherapy; 2004; 6(5):498-504. PubMed ID: 15512916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
